Scullion JE - Search Results

1

Idiopathic chronic cough and organ-specific autoimmune diseases: a case-control study.

Birring SS, Murphy AC, Scullion JE, Brightling CE, Browning M, Pavord ID. Birring SS, et al. Among authors: scullion je. Respir Med. 2004 Mar;98(3):242-6. doi: 10.1016/j.rmed.2003.10.005. Respir Med. 2004. PMID: 15002760 Free article.

2

Management of Fracture Risk in Patients with Chronic Obstructive Pulmonary Disease (COPD): Building a UK Consensus Through Healthcare Professional and Patient Engagement.

Gupta A, Jayes LR, Holmes S, Sahota O, Canavan M, Elkin SL, Lim K, Murphy AC, Singh S, Towlson EA, Ward H, Scullion J, McKeever TM, Bolton CE. Gupta A, et al. Int J Chron Obstruct Pulmon Dis. 2020 Jun 15;15:1377-1390. doi: 10.2147/COPD.S233398. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32606647 Free PMC article.

3

Erectile dysfunction in COPD: A hidden co-morbidity.

Scullion JE, Vincent E. Scullion JE, et al. Chron Respir Dis. 2016 Feb;13(1):3-4. doi: 10.1177/1479972315616932. Chron Respir Dis. 2016. PMID: 26846583 Free PMC article. No abstract available.

4

As-required versus regular nebulized salbutamol for the treatment of acute severe asthma.

Bradding P, Rushby I, Scullion J, Morgan MD. Bradding P, et al. Eur Respir J. 1999 Feb;13(2):290-4. doi: 10.1034/j.1399-3003.1999.13b12.x. Eur Respir J. 1999. PMID: 10065670 Free article. Clinical Trial.

5

Breathing exercises for asthma: a randomised controlled trial.

Thomas M, McKinley RK, Mellor S, Watkin G, Holloway E, Scullion J, Shaw DE, Wardlaw A, Price D, Pavord I. Thomas M, et al. Thorax. 2009 Jan;64(1):55-61. doi: 10.1136/thx.2008.100867. Epub 2008 Dec 3. Thorax. 2009. PMID: 19052047 Clinical Trial.

6

The Nurse Practitioners' Perspective on Inhaler Education in Asthma and Chronic Obstructive Pulmonary Disease.

Scullion J. Scullion J. Can Respir J. 2018 Aug 5;2018:2525319. doi: 10.1155/2018/2525319. eCollection 2018. Can Respir J. 2018. PMID: 30154941 Free PMC article. Review.

7

Our planet or our patients-is the sky the limit for inhaler choice?

Usmani OS, Scullion J, Keeley D. Usmani OS, et al. Lancet Respir Med. 2019 Jan;7(1):11-13. doi: 10.1016/S2213-2600(18)30497-1. Epub 2018 Dec 12. Lancet Respir Med. 2019. PMID: 30553845 Free article. No abstract available.

8

Is the 'blue' colour convention for inhaled reliever medications important? A UK-based survey of healthcare professionals and patients with airways disease.

Fletcher M, Scullion J, White J, Thompson B, Capstick T. Fletcher M, et al. NPJ Prim Care Respir Med. 2016 Nov 3;26:16081. doi: 10.1038/npjpcrm.2016.81. NPJ Prim Care Respir Med. 2016. PMID: 27808097 Free PMC article.

9

Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers.

Keeley D, Scullion JE, Usmani OS. Keeley D, et al. Among authors: scullion je. Eur Respir J. 2020 May 27;55(5):2001122. doi: 10.1183/13993003.01122-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32461340 Free article. No abstract available.

10

Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers.

Keeley D, Scullion JE, Usmani OS. Keeley D, et al. Among authors: scullion je. Eur Respir J. 2020 Feb 27;55(2):2000048. doi: 10.1183/13993003.00048-2020. Print 2020 Feb. Eur Respir J. 2020. PMID: 32108081 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters